Latest Conference Coverage
Gearing Up For the 2022 ACTRIMS Forum: Jeffrey Cohen, MD
February 24th 2022The professor of neurology at Cleveland Clinic and president of ACTRIMS noted his excitement for this year’s Forum, which will feature presentations on a variety of topics in the field of multiple sclerosis. [WATCH TIME: 2 minutes]
Takeaways, Highlights From the Institutional Perspectives in Neurology: MS: Eric Klawiter, MD, MSc
February 18th 2022The director of the Multiple Sclerosis and Neuromyelitis Optica Unit at Massachusetts General Hospital commented on presentations given at the recent event, as well as key takeaways from his own discussion on novel imaging approaches in multiple sclerosis. [WATCH TIME: 2 minutes]
Discussing Novel Imaging Outcomes in Multiple Sclerosis: Eric Klawiter, MD, MSc
February 17th 2022The director of the Multiple Sclerosis and Neuromyelitis Optica Unit at Massachusetts General Hospital outlined a presentation he gave at a recent Institutional Perspectives in Neurology: MS event. [WATCH TIME: 3 minutes]
Understanding Differences in B-Cell Depleting Medications for MS: Kristin Galetta, MD, MSEd
February 15th 2022The professor of neurology at Brigham and Women’s Hospital discussed her presentation on B-cell depleting therapies such as ocrelizumab and ofatumumab for the treatment of multiple sclerosis. [WATCH TIME: 2 minutes]
EVT Reduces Physical Limitations, Improves 90-Day Outcomes Over Standard Therapy in Severe Stroke
February 13th 2022A greater proportion of those treated with EVT had modified Rankin Scale scores of 0-3 at 90 days and NIHSS improvements of at least 8 points or more at 48 hours, relative to standard medical therapy.
Deep Learning Algorithm Shows High Accuracy in Predicting ICH Hematoma Expansion
February 10th 2022The artificial neural network demonstrated an area under the precision-recall curve of 0.92 with recall of 0.72 with precision of 0.39 during testing, all values that were greater than classic regression models.
Use of Seizure Apps During the Pandemic, Need for Data: Jessica Fesler, MD, MEd
January 21st 2022The staff epileptologist at Cleveland Clinic’s Epilepsy Center gave her expert opinion on whether seizure app usage has increased during the COVID-19 pandemic and why there remains a need for further data collections. [WATCH TIME: 2 minutes]
NeuroVoices: Irene Wang, PhD, on the Future of MR Fingerprinting and its Impact on Epilepsy Surgery
January 19th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center provided an inside look at the ways MR fingerprinting can provide real-time clinical benefit for physicians and patient care.
Advantages and Potential of MR Fingerprinting in Epilepsy, Neurology: Irene Wang, PhD
January 18th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed opportunities for MR fingerprinting to expand, both in the epilepsy field and in general neurology. [WATCH TIME 3 minutes]
Improving Recognition, Diagnosis of Psychogenic Nonepileptic Seizures: Becky Tilahun, PhD
January 14th 2022The clinical psychologist at Cleveland Clinic provided insight on the tricky nature of diagnosing a patient with nonepileptic seizures and the difficult conversations that can ensue. [WATCH TIME: 3 minutes]
Using Radiomics-Based MR Fingerprinting to Detect Focal Cortical Dysplasia: Irene Wang, PhD
January 13th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center provided insight on her study presented at AES 2021, which showed that MR fingerprinting can differentiate focal cortical dysplasia from healthy tissue. [WATCH TIME: 4 minutes]
